U.S. markets open in 37 minutes
  • S&P Futures

    4,410.50
    +26.50 (+0.60%)
     
  • Dow Futures

    34,366.00
    +237.00 (+0.69%)
     
  • Nasdaq Futures

    15,245.00
    +81.50 (+0.54%)
     
  • Russell 2000 Futures

    2,234.40
    +19.50 (+0.88%)
     
  • Crude Oil

    71.97
    -0.26 (-0.36%)
     
  • Gold

    1,769.50
    -9.30 (-0.52%)
     
  • Silver

    22.72
    -0.19 (-0.82%)
     
  • EUR/USD

    1.1733
    +0.0037 (+0.32%)
     
  • 10-Yr Bond

    1.3400
    +0.0040 (+0.30%)
     
  • Vix

    19.37
    -4.99 (-20.48%)
     
  • GBP/USD

    1.3721
    +0.0102 (+0.75%)
     
  • USD/JPY

    110.0800
    +0.3020 (+0.28%)
     
  • BTC-USD

    43,694.29
    +1,511.98 (+3.58%)
     
  • CMC Crypto 200

    1,096.05
    +55.57 (+5.34%)
     
  • FTSE 100

    7,079.42
    -3.95 (-0.06%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

FDA aiming to give final approval to Pfizer vaccine by early next month -NY Times

·1 min read
FILE PHOTO: Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken

WASHINGTON (Reuters) -The U.S. Food and Drug Administration is aiming to give full approval for the Pfizer COVID vaccine by early September, the New York Times reported on Tuesday, citing people involved in the effort.

The FDA gave emergency use authorization to the Pfizer vaccine late last year. Full approval by the FDA could push more Americans to get the COVID-19 vaccine as it might reduce their fears about the safety of the shot.

The agency's unofficial deadline for the approval is the Sept. 6 Labor Day holiday, the Times said.

President Joe Biden said last week he expected the FDA to make the decision by early fall.

The FDA said in a statement on Friday that the agency is moving as rapidly as possible on the Pfizer application.

The spread of the highly contagious coronavirus Delta variant has fueled a new surge in infections, with the CDC reporting rising numbers of cases in nearly 90% of U.S. jurisdictions.

(Reporting by Eric Beech; Editing by Sandra Maler and Stephen Coates)